0001437749-23-010521.txt : 20230418 0001437749-23-010521.hdr.sgml : 20230418 20230418114140 ACCESSION NUMBER: 0001437749-23-010521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230415 FILED AS OF DATE: 20230418 DATE AS OF CHANGE: 20230418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gaal Lubor CENTRAL INDEX KEY: 0001822638 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37411 FILM NUMBER: 23825962 MAIL ADDRESS: STREET 1: C/O TIMBER PHARMACEUTICALS, INC. STREET 2: 900 E. HAMILTON AVENUE, SUITE 100 CITY: CAMPBELL STATE: CA ZIP: 95008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Timber Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001504167 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593843182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MOUNTAINVIEW ROAD, SUITE 100 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: (917) 697-3130 MAIL ADDRESS: STREET 1: 3 MOUNTAINVIEW ROAD, SUITE 100 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: BioPharmX Corp DATE OF NAME CHANGE: 20140304 FORMER COMPANY: FORMER CONFORMED NAME: THOMPSON DESIGNS INC DATE OF NAME CHANGE: 20101022 4 1 rdgdoc.xml GAAL FORM 4 X0407 4 2023-04-15 0001504167 Timber Pharmaceuticals, Inc. TMBR 0001822638 Gaal Lubor C/O TIMBER PHARMACEUTICALS, INC. 3 MOUNTAINVIEW RD, SUITE 100 WARREN NJ 07059 1 0 Common Stock, par value $0.001 per share 2023-04-15 4 A 0 4100 0 A 6100 D Stock Option (right to buy) 1.66 2023-04-15 4 A 0 4100 0 A 2032-04-14 Common Stock 4100 4100 D On April 15, 2023, the Reporting Person was granted 4,100 restricted stock units, which will be settled in shares of common stock, par value $0.001. The restricted stock units vest in 12 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date. 25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date. /s/ Joseph Lucchese, Power of Attorney 2023-04-18